Literature DB >> 26880272

The Use of Ultrasound to Improve Axillary Vein Access and Minimize Complications during Pacemaker Implantation.

Abdullah Esmaiel1, Jeremy Hassan2, Fay Blenkhorn2, Vartan Mardigyan2.   

Abstract

BACKGROUND: The Agency for Healthcare Research and Quality in the United States recommends the use of ultrasound (US) for central venous access to improve patient outcomes. However, in a recent publication, US is still underutilized for axillary vein access during pacemaker implantation.
OBJECTIVE: We sought to describe a technique for US-guided axillary vein access during pacemaker implantation and to report complication rates and success rate.
METHODS: Retrospective data collection included success rate and complications on all pacemaker implants by one operator since implementing the systematic use of US at our institution, from November 2012 to January 2015. For the last 59 cases, data were collected prospectively to include time of venous access and number of attempts.
RESULTS: A total of 403 consecutive patients were included in the analysis. Two leads were implanted in 255 cases and one lead was implanted in 148 cases. The rate of successful US-guided access was 99.25%. There were no access-related complications. The average number of venipuncture attempts was 1.18 per patient. The average time to obtain venous access was 2.24 minutes including the time to apply the sterile US sleeve.
CONCLUSION: The described technique has the potential to improve the success rate of axillary vein access and minimize complications during pacemaker implantation. ©2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  axillary vein; central venous access; pacemaker; techniques; ultrasound

Mesh:

Year:  2016        PMID: 26880272     DOI: 10.1111/pace.12833

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

Review 1.  Pregnancy in patients with implantable cardiac defibrillators.

Authors:  Geoffrey R Wong; Megan Ang; Jasveer Jayarajan; Fiona Walker; Pier D Lambiase
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-05-10

2.  Feasibility of ultrasound-guided vascular access during cardiac implantable device placement.

Authors:  Jeffrey Lin; Graham Adsit; Anne Barnett; Matthew Tattersall; Michael E Field; Jennifer Wright
Journal:  J Interv Card Electrophysiol       Date:  2017-07-27       Impact factor: 1.900

3.  Efficacy of ultrasound-guided axillary/subclavian venous approaches for pacemaker and defibrillator lead implantation: a randomized study.

Authors:  Mattia Liccardo; Pasquale Nocerino; Salzano Gaia; Carmine Ciardiello
Journal:  J Interv Card Electrophysiol       Date:  2018-01-15       Impact factor: 1.900

4.  A comparison of longitudinal and transverse approaches to ultrasound-guided axillary vein cannulation by experienced operators.

Authors:  Yi-Zhou He; Ming Zhong; Wei Wu; Jie-Qiong Song; Du-Ming Zhu
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

5.  Editorial Comment to: Perioperative complications after pacemaker implantation: Higher complication rates with subclavian vein puncture than with cephalic vein cut-down (Hasan et al.).

Authors:  Yury Malyshev; Felix Yang
Journal:  J Interv Card Electrophysiol       Date:  2022-05-02       Impact factor: 1.900

Review 6.  Strategies to Promote Long-Term Cardiac Implant Site Health.

Authors:  Jane Taleski; Biljana Zafirovska
Journal:  Cureus       Date:  2021-01-03

7.  A Practical Guide to Ultrasound-guided Venous Access During Implantation of Pacemakers and Defibrillators.

Authors:  Dingxin Qin; Leon M Ptaszek
Journal:  J Innov Card Rhythm Manag       Date:  2022-02-15

8.  Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy.

Authors:  Luiz Eduardo Montenegro Camanho; Eduardo Benchimol Saad; Charles Slater; Luiz Antonio Oliveira Inacio Junior; Gustavo Vignoli; Lucas Carvalho Dias; Pedro Pimenta de Mello Spineti; Ricardo Mourilhe-Rocha
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.